The steroid RU486 induces UCP1 expression in brown adipocytes

作者: Ana M. Rodr�guez , Andreu Palou

DOI: 10.1007/S00424-004-1329-7

关键词:

摘要: RU486 (mifepristone), a potent antagonist at progesterone and glucocorticoid receptors (PR GR), is well known for its use in the termination of unwanted pregnancies, potential development oral contraceptives, treatment certain cancers other activities. Potentially, it could also play role obesity control, although few studies that have addressed this aspect focused mainly on central anti-glucocorticoid effects. We shown previously direct effect brown adipocytes culture when administered together with progesterone. The aim present work was to analyse effects expression uncoupling proteins (UCPs) adipocytes. In culture-grown, differentiated adipocytes, placed serum-free medium exclude presence or glucocorticoids, stimulated UCP1 both mRNA protein levels. These be mediated by PR, GR unknown mechanisms but do not seem due anti-progestin actions. results suggest steroid has action which useful stimulating non-shivering BAT thermogenesis therefore interest studies.

参考文章(24)
S. C. Langley, D. A. York, Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 259, ,(1990) , 10.1152/AJPREGU.1990.259.3.R539
Nicholas C. Turner, John C. Clapham, Effects of the glucocorticoid II receptor antagonist mifepristone on hypertension in the obese Zucker rat. Journal of Pharmacology and Experimental Therapeutics. ,vol. 282, pp. 1503- 1508 ,(1997)
A. Moriscot, R. Rabelo, A. C. Bianco, Corticosterone inhibits uncoupling protein gene expression in brown adipose tissue American Journal of Physiology-endocrinology and Metabolism. ,vol. 265, ,(1993) , 10.1152/AJPENDO.1993.265.1.E81
Irving M. Spitz, Proven and potential clinical applications of mifpristone (RU486). Reviews in Endocrine & Metabolic Disorders. ,vol. 3, pp. 267- 275 ,(2002) , 10.1023/A:1020032711706
M A Glotzer, U Stadler, L P Kozak, A Jacobsson, Mitochondrial uncoupling protein from mouse brown fat: molecular cloning, genetic mapping, and mRNA expression Journal of Biological Chemistry. ,vol. 260, pp. 16250- 16254 ,(1985) , 10.1016/S0021-9258(17)36228-2
S. Okada, D. A. York, G. A. Bray, Mifepristone (RU 486), a blocker of type II glucocorticoid and progestin receptors, reverses a dietary form of obesity. American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 262, ,(1992) , 10.1152/AJPREGU.1992.262.6.R1106
Horacio B. Croxatto, Mifepristone for luteal phase contraception Contraception. ,vol. 68, pp. 483- 488 ,(2003) , 10.1016/S0010-7824(03)00182-3